George E. Pentheroudakis
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Diagnosis and Treatment
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 164
- Cancer Diagnosis and Treatment 43
- Colorectal Cancer Treatments and Studies 32
- HER2/EGFR in Cancer Research 16
-
- Tumors and Oncological Cases 25
- Co-authors
- Nicholas A. Pavlidis (83 shared papers)M. Brada (2 shared papers)Roger Stupp (2 shared papers)Maria Grazia Castagna (3 shared papers)Lucia Brilli (3 shared papers)Furio Pacini (3 shared papers)J.-C. Tonn (1 shared paper)Martin J. van den Bent (1 shared paper)
In The Last Decade
George E. Pentheroudakis
294 papers receiving 14.3k citations
George E. Pentheroudakis's Hit Papers
Peers
Comparison fields: 5 of 143
- Oncology 7.2k
- Hepatology 1.2k
- Cancer Research 2.1k
- Pathology and Forensic Medicine 1.9k
- Oral Surgery 719
Countries citing papers authored by George E. Pentheroudakis
This map shows the geographic impact of George E. Pentheroudakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Pentheroudakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Pentheroudakis more than expected).
Fields of papers citing papers by George E. Pentheroudakis
This network shows the impact of papers produced by George E. Pentheroudakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Pentheroudakis. The network helps show where George E. Pentheroudakis may publish in the future.
Co-authors
The 25 scholars most cited alongside George E. Pentheroudakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 298 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Hit paper breakdown → | 2016 | 2659 |
| 2 | High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2014 | 620 |
| 3 | ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group Hit paper breakdown → | 2022 | 509 |
| 4 | Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS Hit paper breakdown → | 2017 | 460 |
| 5 | Cancer of unknown primary site Hit paper breakdown → | 2012 | 429 |
| 6 | 2015 | 303 | |
| 7 | 2010 | 297 | |
| 8 | 2010 | 295 | |
| 9 | 2015 | 269 | |
| 10 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS Hit paper breakdown → | 2018 | 253 |
| 11 | ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer Hit paper breakdown → | 2023 | 227 |
| 12 | 2012 | 226 | |
| 13 | 2005 | 203 | |
| 14 | 2007 | 200 | |
| 15 | Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review Hit paper breakdown → | 2023 | 197 |
| 16 | 2018 | 186 | |
| 17 | 2012 | 180 | |
| 18 | 2020 | 178 | |
| 19 | ESMO Guidance for Reporting Oncology real-World evidence (GROW) Hit paper breakdown → | 2023 | 150 |
| 20 | Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. | 2012 | 149 |
About George E. Pentheroudakis
George E. Pentheroudakis is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Oral Surgery and Pulmonary and Respiratory Medicine, having authored 298 papers that have together received 14.7k indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (43 papers), Colorectal Cancer Treatments and Studies (32 papers), Tumors and Oncological Cases (25 papers), Oral and Maxillofacial Pathology (21 papers), Cancer Genomics and Diagnostics (19 papers), HER2/EGFR in Cancer Research (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Breast Cancer Treatment Studies (15 papers). The work is most often cited by research in Oncology (7.2k citations), Hepatology (1.2k citations), Cancer Research (2.1k citations), Pathology and Forensic Medicine (1.9k citations) and Oral Surgery (719 citations). George E. Pentheroudakis has collaborated with scholars based in Greece, Italy and Germany. Frequent co-authors include Nicholas A. Pavlidis, M. Brada, Roger Stupp, Maria Grazia Castagna, Lucia Brilli, Furio Pacini, J.-C. Tonn, Martin J. van den Bent, George Fountzilas and Reinhard Dummer. Their work appears in journals such as Annals of Oncology, ESMO Open, Cancer Treatment Reviews, PLoS ONE and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.